H. Celik Et Al. , "Hyperhomocysteinemia may be a resistance factor in tocolytic treatment with beta mimetics," MEDICAL HYPOTHESES , vol.61, pp.580-582, 2003
Celik, H. Et Al. 2003. Hyperhomocysteinemia may be a resistance factor in tocolytic treatment with beta mimetics. MEDICAL HYPOTHESES , vol.61 , 580-582.
Celik, H., Ayar, A., & Tug, N., (2003). Hyperhomocysteinemia may be a resistance factor in tocolytic treatment with beta mimetics. MEDICAL HYPOTHESES , vol.61, 580-582.
Celik, H, AHMET AYAR, And N Tug. "Hyperhomocysteinemia may be a resistance factor in tocolytic treatment with beta mimetics," MEDICAL HYPOTHESES , vol.61, 580-582, 2003
Celik, H Et Al. "Hyperhomocysteinemia may be a resistance factor in tocolytic treatment with beta mimetics." MEDICAL HYPOTHESES , vol.61, pp.580-582, 2003
Celik, H. Ayar, A. And Tug, N. (2003) . "Hyperhomocysteinemia may be a resistance factor in tocolytic treatment with beta mimetics." MEDICAL HYPOTHESES , vol.61, pp.580-582.
@article{article, author={H Celik Et Al. }, title={Hyperhomocysteinemia may be a resistance factor in tocolytic treatment with beta mimetics}, journal={MEDICAL HYPOTHESES}, year=2003, pages={580-582} }